ECM誘発のIL-23は,TregsのPD-1を調節することにより,乳がんにおける免疫抑制を誘発する
Giovanna Talarico1,2, Mara Lecchi3, Anna Zanichelli1
1Molecular Immunology Unit, Experimental Oncology Department, Fondazione IRCCS Istituto Nazionale Dei Tumori di Milano, Milan, Italy.
Journal of experimental & clinical cancer research : CR
|September 2, 2025
まとめ
高度乳がんの細胞外マトリックス (ECM) はT細胞に影響します. ECM3陽性腫瘍のSPARCタンパク質はT細胞活動を抑制し,PD-1/PD- L1阻害を超えた新しい治療標的を示唆する.
科学分野:
- 腫瘍学
- 免疫学
- 癌 生物学
背景:
- 高度乳がん (HGBC) は攻撃的であり,新しい治療法が必要である.
- 腫瘍の微小環境 (TME),特に細胞外マトリックス (ECM) は,腫瘍の進行と治療抵抗に影響します.
- HGBCにおけるECM関連遺伝子シグネチャー (ECM3) は,侵襲性疾患,上皮からメゼンキマへの移行 (EMT),免疫抑制と相関しています.
研究 の 目的:
- HGBCにおけるT細胞調節に対するECMの影響を調査する.
- ECM3陽性腫瘍とT細胞フェノタイプとの関係を調査する.
- ECMの構成要素,特にSPARCをT細胞調節に結びつける分子メカニズムを解明する.
主な方法:
- ECM3陽性腫瘍を有するHGBC患者におけるT細胞フェノタイプの分析
- ECM媒介のT細胞調節を研究するためにマウスモデルを使用.
- ECM3シグネチャーにおけるマトリセルタンパク質SPARCの役割に焦点を当てています.
主要な成果:
- ECM3陽性腫瘍と抑制性プログラム細胞死-1 (PD-1) 陰性調節性T細胞 (Tregs) の間には相関が認められた.
- SPARCはIL-23とSATB1誘導によってTエフェクタ細胞のPD-1をダウン調節し,Tエフェクタ細胞を抑制する.
- IL- 23を阻害すると,Tレグ細胞のPD- 1が回復し,Tエフェクタ細胞が活性化され,重要な調節経路が示された.
結論:
- ECMは,HGBCのT細胞 (Tregs) を含むT細胞を調節する.
- SPARCとIL-23のシグナリングは,HGBCの潜在的な治療目標です.
- ECM3はPD-1/PD-L1免疫チェックポイント阻害 (ICB) に対する耐性のバイオマーカーとして機能し,代替療法からの潜在的な利益を示唆する.
関連する概念動画
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.3K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.3K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K


